Work

Multi-Omic Single-Cell Sequencing Reveals Genetic and Immunophenotypic Clonal Selection in Patients With FLT3-Mutated AML Treated With Gilteritinib/Venetoclax

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-160304

Authors: Vanessa E. Kennedy, Cheryl Peretz, Paul Lee, Brenda Chyla, Yan Sun, Monique Dail, Jason Hill, Elaine Tran, Andrew Koh, Jessica K. Altman, Naval Daver, Mark J. Levis, James McCloskey, Alexander Perl, Catherine Smith

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, AbbVie (United States), Genentech, Astellas Pharma (United States), Northwestern University, The University of Texas MD Anderson Cancer Center, Johns Hopkins University, Hackensack University Medical Center, University of Pennsylvania

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310103494

FWCI: 0.783

Cites:

Cited by: 5

Related to: 10